Haemolytic disease of the foetus and new-born
Authors:
H. Kostrouchová 1; J. Tylečková 1; R. Gerychová 2
Authors‘ workplace:
Transfuzní a tkáňové oddělení, FN Brno
1; Gynekologicko-porodnická klinika FN Brno
2
Published in:
Transfuze Hematol. dnes,28, 2022, No. 4, p. 221-225.
Category:
Case Report
doi:
https://doi.org/doi: 10.48095/cctahd2022prolekare.cz13
Overview
This case report describes Rh incompatibility during pregnancy. A pregnant woman with a history of RhD haemolytic disease of the foetus and new-born 6 years ago, presented in the 10th week of her current gestation with an already very high titre of the anti-D alloantibody. Further immunisation with anti-C and anti-G alloantibodies followed. Severe anaemia of the foetus required intrauterine transfusion treatment from the 22nd gestational week.
Keywords:
haemolytic disease of the foetus and new-born – red blood cell antibodies – intrauterine transfusion – Rh(D) immunoprophylaxis – anti-G
Sources
1. Masopust J, Písačka M. Praktická imunohematologie Erytrocyty. 1. vyd. Praha, Mladá fronta a. s., 2016.
2. Solheim BG, Grönn M, Hansen TWR. Hemolytic disease of the fetus and newborn. In: Simon TL, McCullough J, Snyder EL, Solheim BG, Strauss R. G. Rossi‘s Principles of Transfusion Medicine. 5th edition UK, John Wiley & Sons, Ltd., 2016; 528–534.
3. Doporučení Společnosti pro transfuzní lékařství ČLS JEP č. STL2010_06 ze dne 1. 3. 2010 verze 3 (2010_06). Imunohematologická vyšetření v těhotenství a po porodu. Dostupné na: https: //www.transfuznispolecnost.cz/doporuceni-stl/doporuceni-stl-c-6-imunohematologicka-vysetreni-v-tehotenstvi-a-po-porodu-12 231
4. Ľubušký M, Holusková I, Procházka M, Hálek J, Klásková E. České gynekologické a porodnické společnosti ČLS JEP ze dne 2. 12. 2016. Management těhotenství s rizikem rozvoje hemolytické nemoci plodu a novorozence. Doporučený postup. Ceska Gynekol 2017; 82 (1): 82–84.
5. International Society of Blood Transfusion; Immunohematology Case Studies 2020–4. Dostupné na: https: //www.isbtweb.org/isbt-working-parties/immunohaematology/resources/immunohaematology-case-studies.html
6. Delaney M, Matthews DC. Hemolytic dis- ease of the fetus and newborn: managing the mother, fetus, and newborn. Hematology Am Soc Hematol Educ Program 2015. 2015; (1): 146–151.
7. Doporučení Společnosti pro transfuzní lékařství ČLS JEP č. STL2015_12 ze dne 01. 09. 2015 verze 1. Doporučené postupy pro podání transfuzních přípravků. Dostupné na: https: //www.transfuznispolecnost.cz/doporuceni-stl/doporuceni-stl-c-12-doporucene-postupy-pro-podani-transfuznich-pripravku-12 225
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2022 Issue 4
Most read in this issue
- Haemolytic disease of the foetus and new-born
- Beta-thalassemia minor and maior in pregnancy
- Current experience with ropeginterferon Alfa-2b in Ph negative myeloproliferative neoplasm at the Department of Internal Medicine – Haematology and Oncology in Brno
- How do anti-SARS-CoV-2 IgG and IgM predict the titre of virus-neutralizing antibodies in donors of convalescent plasma against COVID-19 disease?